NBEAL1 and cerebral small vessel disease: NBEAL1 have been detected previously in a GWAS of cerebral small vessel disease [28] and was found to affect cellular cholesterol metabolism and LDL uptake and was associated with coronary artery diseases [33], indicating that NBEAL1 may influence the risk of stroke by LDL.